0001235802-22-000130.txt : 20221205 0001235802-22-000130.hdr.sgml : 20221205 20221205161642 ACCESSION NUMBER: 0001235802-22-000130 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221205 FILED AS OF DATE: 20221205 DATE AS OF CHANGE: 20221205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pilnik Richard D. CENTRAL INDEX KEY: 0001760016 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36291 FILM NUMBER: 221445156 MAIL ADDRESS: STREET 1: 2 CARLSON PARKWAY STREET 2: SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc. CENTRAL INDEX KEY: 0001401040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 CARLSON PARKWAY STREET 2: SUITE 210 CITY: MINNEAPOLIS STATE: MN ZIP: 55305 BUSINESS PHONE: (763) 496-5454 MAIL ADDRESS: STREET 1: 301 CARLSON PARKWAY STREET 2: SUITE 210 CITY: MINNEAPOLIS STATE: MN ZIP: 55305 FORMER COMPANY: FORMER CONFORMED NAME: DiaMedica Inc. DATE OF NAME CHANGE: 20070525 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2022-12-05 0 0001401040 DiaMedica Therapeutics Inc. DMAC 0001760016 Pilnik Richard D. 301 CARLSON PARKWAY, SUITE 210 MINNEAPOLIS MN 55305 1 0 0 0 Voting Common Shares, no par value per share 2022-12-05 4 P 0 35000 1.3855 A 154327 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.3665 to $1.4047, inclusive. The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 43,649 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan. /s/ Amy Culbert, attorney-in-fact 2022-12-05